TI
LGND icon

Trexquant Investment’s Ligand Pharmaceuticals LGND Stock Holding History

Trexquant Investment’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,550
Closed -$2.18M – 1915
2025
Q4 		$2.18M Sell
11,550
-32,949
-74% -$6.33M 0.02% 964
2025
Q3 		$7.88M Buy
+44,499
New +$6.62M 0.08% 375
2023
Q3 		– Sell
-21,267
Closed -$1.53M – 1656
2023
Q2 		$1.53M Buy
21,267
+4,916
+30% +$369K 0.04% 598
2023
Q1 		$1.2M Sell
16,351
-7,178
-31% -$510K 0.03% 658
2022
Q4 		$1.57M Sell
23,529
-1,693
-7% -$110K 0.04% 497
2022
Q3 		$1.35M Buy
25,222
+17,730
+237% +$1.04M 0.05% 447
2022
Q2 		$417K Buy
+7,492
New +$425K 0.02% 935
2022
Q1 		– Sell
-5,899
Closed -$568K – 1568
2021
Q4 		$568K Buy
+5,899
New +$545K 0.04% 580
2020
Q4 		– Sell
-10,597
Closed -$630K – 1281
2020
Q3 		$630K Buy
10,597
+1,777
+20% +$121K 0.04% 579
2020
Q2 		$615K Sell
8,820
-10,745
-55% -$681K 0.04% 588
2020
Q1 		$888K Buy
+19,565
New +$1.11M 0.06% 455
2019
Q4 		– Sell
-5,328
Closed -$331K – 1165
2019
Q3 		$331K Sell
5,328
-1,254
-19% -$78.7K 0.03% 584
2019
Q2 		$469K Buy
+6,582
New +$485K 0.04% 480
2019
Q1 		– Sell
-43,260
Closed -$3.66M – 1151
2018
Q4 		$3.66M Buy
43,260
+34,006
+367% +$3.63M 0.23% 126
2018
Q3 		$1.58M Buy
+9,254
New +$1.4M 0.12% 250
2015
Q2 		– Sell
-11,381
Closed -$547K – 1112
2015
Q1 		$547K Sell
11,381
-5,277
-32% -$202K 0.06% 652
2014
Q4 		$552K Buy
+16,658
New +$542K 0.1% 422

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Trexquant Investment's LGND Position: Q1 2026 in Review

Trexquant Investment sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 11,550 shares — an estimated $2.18M sold.

Trexquant Investment first reported a position in LGND in Q4 2014 and held it in 17 quarters. The position peaked at $7.88M in Q3 2025. 358 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Trexquant Investment reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Trexquant Investment sold 11,550 Ligand Pharmaceuticals shares in Q1 2026, an estimated $2.18M.
  • Trexquant Investment first reported a position in Ligand Pharmaceuticals in Q4 2014 and held it in 17 quarters.
  • Trexquant Investment's Ligand Pharmaceuticals position peaked at $7.88M in Q3 2025.
  • 358 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.